Literature DB >> 24398318

Renal function is ameliorated in a diabetic nephropathy rat model through a duodenal-jejunal bypass.

Wang Zhiqing1, Wang Jing2, Xu Haili3, Liu Shaozhuang4, Hu Chunxiao4, Han Haifeng4, Wang Hui5, Hu Sanyuan6.   

Abstract

AIMS: Diabetes surgery is growing in popularity and has been shown to have marked effects on diabetes. However, several studies have shown it may induce some renal injury, and, currently, the impact of diabetes surgery on renal function is unclear. In this study, we examined renal function and histological changes in rats with diabetic nephropathy (DN) following a duodeno-jejunal bypass (DJB) operation.
METHODS: Rats with streptozotocin (STZ)-induced diabetes were randomly assigned to 3 groups: DJB group (DJB), Sham-DJB group (S-DJB) and diabetes group (DM). Six age-matched normal rats were assigned as the control group. DJB and sham surgery were performed. Body weight, food intake, glucose levels, lipid parameters, cystatin C (Cys_C) levels, serum and urinary creatinine, 24h urine albumin excretion rate (UAER) and glomerular filtration rate (GFR) were measured. Histological analysis and immunohistochemical studies of renal sections were also performed.
RESULTS: DJB ameliorated renal function by improving UAER, GFR and Cys_C levels 4 and 8 weeks after surgery. It also improved lipid metabolism by decreasing fasting total serum cholesterol (TC) and triglyceride (TG) levels. Immuno-staining of synaptopodin showed podocyte injury was also improved in DJB glomeruli compared with sham and DM groups. Histological analysis showed that the mesangial expansion was not significantly prevented 8 weeks after DJB surgery.
CONCLUSION: DJB ameliorated renal function in UAER and GFR but not mesangial expansion in a DN rat model. The improvement of renal function may be attributed to reversing the injury or loss of podocytes after DJB surgery.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Diabetic nephropathy; Duodenal-jejunal bypass; Mesangial expansion; Podocyte; Renal function; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2013        PMID: 24398318     DOI: 10.1016/j.diabres.2013.12.001

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  4 in total

1.  Roux-en-Y Esophagojejunostomy Ameliorates Renal Function Through Reduction of Renal Inflammatory and Fibrotic Markers in Diabetic Nephropathy.

Authors:  Cuifang Wang; Bing He; Dongxu Piao; Ping Han
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

Review 2.  Impact of Metabolic Surgery on Renal Injury in Pre-Clinical Models of Diabetic Kidney Disease.

Authors:  William P Martin; Carel W le Roux; Neil G Docherty
Journal:  Nephron       Date:  2020-12-02       Impact factor: 2.847

3.  Preventive effects of betulinic acid on streptozotocinnicotinamide induced diabetic nephropathy in male mouse.

Authors:  Akram Ahangarpour; Ali Akbar Oroojan; Layasadat Khorsandi; Razieh Shabani; Shahnaz Mojaddami
Journal:  J Nephropathol       Date:  2016-08-03

4.  Value of the combined examination of Cys-C and HbA1c for diagnosis of early renal injury in pediatric diabetes.

Authors:  Tong Qian; Lijun Tian; Yanyan Li; Zhenru Zhang; Xiuying Tian; Dan Sun
Journal:  Exp Ther Med       Date:  2016-12-12       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.